MARKSANS — Marksans Pharma Share News
0.000.00%
Last trade - 00:00- IN₹130.01bn
- IN₹123.80bn
- IN₹29.51bn
Brief: Marksans Pharma Announces UK MHRA Approval For Fluoxetine 20Mg/5Ml Oral Solution
Brief: Marksans Pharma Raises 3.72 Billion Rupees Via Conversion Of Warrants Into Shares By Orbimed Asia Iv Mauritius Fvci, Promoter Mark Saldanha
India's Marksans Pharma hits near 7-month high as Q2 profit rises
Brief: India's Marksans Pharma Sept-Quarter Consol Net Profit Rises
Brief: Marksans Pharma Proposes Capacity Addition Of 8 Billion Units Per Annum
India's Marksans Pharma jumps most in over 3 months on capacity acquisition
Brief: Marksans Pharma Acquires Capacity From Tevapharm India
Approved Proposal To Buyback Shares
India's Marksans Pharma jumps over 15% on share buyback proposal
Brief: Marksans Pharma To Consider Proposal For Buyback Of Shares
Brief: Marksans Pharma Unit Recalls Kroger Brand Aspirin, Ibuprofen Due To Label Packaging Issue
Brief: Marksans Pharma Gets Final FDA Approval For Cetirizine Hydrochloride Tablets 5 Mg & 10 Mg
India's Marksans Pharma rises as unit gets nod to market diarrhoea medicine in UK
Brief: Marksans Pharma - UK MHRA Granted Market Authorisation To Unit For Loperamide
Brief: Marksans Pharma Sept-Quarter Consol Profit Falls
June Quarter Consol Profit Rises
Brief: Marksans Pharma March-Quarter Consol Profit Rises
Brief: Marksans Pharma Ltd Dec Quarter Consol Profit Rises
Brief: Marksans Pharma Recalls One Batch Of Metformin Extended Release Tablets 500 Mg Due To NDMA Detection